Ataxin 1 anticorps
Aperçu rapide pour Ataxin 1 anticorps (ABIN865485)
Antigène
Voir toutes Ataxin 1 (ATXN1) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Purification
- Ascitic fluid
-
Immunogène
- Purified recombinant fragment of human ATXN1 expressed in E. Coli.
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- WB: 1/500 - 1/2000, IHC: 1/200 - 1/1000, IF: 1/200 - 1/1000, FC: 1/200-1/400 ELISA: Propose dilution 1/10000. Figure 3: Immunofluorescence
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 100g/100l
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
-
- Ataxin 1 (ATXN1)
-
Autre désignation
- ATXN1
-
Sujet
- The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the `pure' cerebellar syndrome (SCA5), are most likely homogeneous disorders. Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions. ADCA is caused by the expansion of the CAG repeats, producing an elongated polyglutamine tract in the corresponding protein. The expanded repeats are variable in size and unstable, usually increasing in size when transmitted to successive generations. Synonyms: ATX1, SCA1, D6S504E, ATXN1
-
Poids moléculaire
- 87kDa
-
ID gène
- 6310
-
Pathways
- Synaptic Membrane
Antigène
-